BioNTech’s oncology vaccine trial sees all patients living kidney cancer-free
Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping cancer.
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report.
Cancer vaccine prevents recurrence of advanced kidney cancer in small trial
After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to an experimental, personalized cancer vaccine, researchers reported Feb. 5.
Neoantigen vaccine sparks powerful immune defense against kidney cancer
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to long-lasting T cell expansion and no disease recurrence after 40 months.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the vaccine candidate appeared to be safe and produced a clear immune response in all nine patients at high risk for recurrences of their cancer.
New Vaccine Shows Promise For Kidney Cancer
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer three years after the pioneering treatment.
Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated robust immune response, according to findings of a new study led by HMS researchers at Dana-Farber Cancer Institute.
Immunogenic Cancer Vaccine Targets Key Mutations in Kidney Cancer
Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, according to a study published online Feb.
Boston researchers make progress in kidney cancer vaccine
Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune system to eliminate tumor cells.
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a significant advancement for a cancer type that traditionally has limited treatment options.
'Exciting' cancer vaccine offers hope for patients
Lesley Jenkins had surgery to remove a tumour that was discovered following a routine bowel test.
Legal experts say RFK Jr.'s move to give financial interest in vaccine lawsuits to family is 'not unusual'
Amid scrutiny over Robert F. Kennedy Jr.'s pledge to divest his financial stake in vaccine lawsuits to his family, legal ...
Unintended consequences of halting vaccine research: more cancer deaths?
Like infectious diseases, cancer will not observe a moratorium, and a halt in government vaccine research funding will ...
cnbctv183d
World Cancer Day: How AI can help in developing personalised cancer vaccines
The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...
Medscape19h
Personalized Neoantigen Vaccine Shows Promise in High-Risk Renal Cell Carcinoma
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
500 underprivileged girls in Bengaluru receive free HPV vaccines to prevent cervical cancer: Report
In a bid to tackle cervical cancer, one of the leading causes of cancer-related deaths among women, 500 adolescent girls from ...
Targeted Oncology1d
No RCC Recurrence in Patients Treated With Adjuvant Neoantigen Vaccine
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...
New cancer vaccine to beat disease and stop it coming back given in Wales
Clinical trial using the same technology as Covid-19 vaccines is designed to fight colorectal cancer and prevent it from ...